(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) fell 8.72% to $30.57 at 10:53 EST on Tuesday, after three successive sessions in a row of losses. NASDAQ is sliding 0.65% to $13,043.21, after two consecutive sessions in a row of gains. This seems, so far, a somewhat bearish trend exchanging session today.

Castle Biosciences’s last close was $33.49, 57.38% under its 52-week high of $78.58.


Today’s last reported volume for Castle Biosciences is 31751 which is 89.87% below its average volume of 313579.

The company’s growth estimates for the current quarter and the next is a negative 114.3% and a negative 68.1%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.


Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 2.39%, 1.57%, and 4.77%, respectively.

Castle Biosciences’s highest amplitude of average volatility was 3.62% (last week), 3.48% (last month), and 4.77% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Castle Biosciences’s stock is considered to be overbought (>=80).

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $30.57 at 10:53 EST, way below its 52-week high of $78.58 and way higher than its 52-week low of $15.58.

Castle Biosciences’s Moving Average

Castle Biosciences’s value is way above its 50-day moving average of $22.43 and way below its 200-day moving average of $36.79.

More news about Castle Biosciences (CSTL).


Please enter your comment!
Please enter your name here